APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bendamustine

Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein.

Selected research

Market Analysis & Forecast

Global Bendamustine Market Analysis and Forecast 2026-2032

Report ID 17396965021 January 2026195 pages

Choose your research edition.

Industry ResearchBendamustine Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Bendamustine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Bendamustine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bendamustine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Bendamustine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein.

Market competition is intense. Teva, Eisai, Eagle Pharmaceuticals, MundiPharma, Mylan, Natco Pharma, Emcure, etc. are the leaders of the industry, with Teva occupies the major markets share of over 83% in 2018.

This report presents an overview of global market for Bendamustine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Bendamustine, also provides the sales of main regions and countries. Of the upcoming market potential for Bendamustine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bendamustine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bendamustine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Bendamustine sales, projected growth trends, production technology, application and end-user industry.

Bendamustine Segment by Company

Teva

Eisai

Eagle Pharmaceuticals

MundiPharma

Mylan

Natco Pharma

Emcure

Miracalus Pharma

Bendamustine Segment by Type

25mg Injection

100mg Injection

Others

Bendamustine Segment by Application

Chronic Lymphocytic Leukemia

Multiple Myeloma

Non-Hodgkin's Lymphoma

Bendamustine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bendamustine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bendamustine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bendamustine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Bendamustine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Bendamustine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bendamustine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bendamustine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 25mg Injection Major Manufacturers Table 3. 100mg Injection Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Bendamustine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Chronic Lymphocytic Leukemia Major Manufacturers Table 7. Multiple Myeloma Major Manufacturers Table 8. Non-Hodgkin's Lymphoma Major Manufacturers Table 9. Bendamustine Industry Trends Table 10. Bendamustine Industry Drivers Table 11. Bendamustine Industry Opportunities and Challenges Table 12. Bendamustine Industry Restraints Table 13. Global Bendamustine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Bendamustine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Bendamustine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Bendamustine Revenue Market Share by Region (2021-2026) Table 17. Global Bendamustine Revenue Market Share by Region (2027-2032) Table 18. Global Bendamustine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Bendamustine Sales by Region (2021-2026) & (K Units) Table 20. Global Bendamustine Sales by Region (2027-2032) & (K Units) Table 21. Global Bendamustine Sales Market Share by Region (2021-2026) Table 22. Global Bendamustine Sales Market Share by Region (2027-2032) Table 23. Global Bendamustine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Bendamustine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Bendamustine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Bendamustine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Bendamustine Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 28. Global Bendamustine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Bendamustine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Bendamustine Manufacturers, Product Type & Application Table 31. Global Bendamustine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Bendamustine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Bendamustine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Bendamustine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Bendamustine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Bendamustine Revenue Market Share by Type (2021-2026) Table 38. Global Bendamustine Revenue Market Share by Type (2027-2032) Table 39. Global Bendamustine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Bendamustine Sales by Type (2021-2026) & (K Units) Table 41. Global Bendamustine Sales by Type (2027-2032) & (K Units) Table 42. Global Bendamustine Sales Market Share by Type (2021-2026) Table 43. Global Bendamustine Sales Market Share by Type (2027-2032) Table 44. Global Bendamustine Price by Type (2021-2026) & (USD/Unit) Table 45. Global Bendamustine Price by Type (2027-2032) & (USD/Unit) Table 46. Global Bendamustine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Bendamustine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Bendamustine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Bendamustine Revenue Market Share by Application (2021-2026) Table 50. Global Bendamustine Revenue Market Share by Application (2027-2032) Table 51. Global Bendamustine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Bendamustine Sales by Application (2021-2026) & (K Units) Table 53. Global Bendamustine Sales by Application (2027-2032) & (K Units) Table 54. Global Bendamustine Sales Market Share by Application (2021-2026) Table 55. Global Bendamustine Sales Market Share by Application (2027-2032) Table 56. Global Bendamustine Price by Application (2021-2026) & (USD/Unit) Table 57. Global Bendamustine Price by Application (2027-2032) & (USD/Unit) Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Teva Bendamustine Product Portfolio Table 62. Teva Recent Development Table 63. Eisai Company Information Table 64. Eisai Business Overview Table 65. Eisai Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Eisai Bendamustine Product Portfolio Table 67. Eisai Recent Development Table 68. Eagle Pharmaceuticals Company Information Table 69. Eagle Pharmaceuticals Business Overview Table 70. Eagle Pharmaceuticals Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Eagle Pharmaceuticals Bendamustine Product Portfolio Table 72. Eagle Pharmaceuticals Recent Development Table 73. MundiPharma Company Information Table 74. MundiPharma Business Overview Table 75. MundiPharma Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. MundiPharma Bendamustine Product Portfolio Table 77. MundiPharma Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Mylan Bendamustine Product Portfolio Table 82. Mylan Recent Development Table 83. Natco Pharma Company Information Table 84. Natco Pharma Business Overview Table 85. Natco Pharma Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Natco Pharma Bendamustine Product Portfolio Table 87. Natco Pharma Recent Development Table 88. Emcure Company Information Table 89. Emcure Business Overview Table 90. Emcure Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Emcure Bendamustine Product Portfolio Table 92. Emcure Recent Development Table 93. Miracalus Pharma Company Information Table 94. Miracalus Pharma Business Overview Table 95. Miracalus Pharma Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Miracalus Pharma Bendamustine Product Portfolio Table 97. Miracalus Pharma Recent Development Table 98. North America Bendamustine Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Bendamustine Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Bendamustine Sales by Type (2021-2026) & (K Units) Table 101. North America Bendamustine Sales by Type (2027-2032) & (K Units) Table 102. North America Bendamustine Sales Price by Type (2021-2026) & (USD/Unit) Table 103. North America Bendamustine Sales Price by Type (2027-2032) & (USD/Unit) Table 104. North America Bendamustine Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Bendamustine Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Bendamustine Sales by Application (2021-2026) & (K Units) Table 107. North America Bendamustine Sales by Application (2027-2032) & (K Units) Table 108. North America Bendamustine Sales Price by Application (2021-2026) & (USD/Unit) Table 109. North America Bendamustine Sales Price by Application (2027-2032) & (USD/Unit) Table 110. North America Bendamustine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Bendamustine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Bendamustine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Bendamustine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 114. North America Bendamustine Sales by Country (2021-2026) & (K Units) Table 115. North America Bendamustine Sales by Country (2027-2032) & (K Units) Table 116. North America Bendamustine Sales Price by Country (2021-2026) & (USD/Unit) Table 117. North America Bendamustine Sales Price by Country (2027-2032) & (USD/Unit) Table 118. United States Bendamustine Revenue (2021-2032) & (US$ Million) Table 119. Canada Bendamustine Revenue (2021-2032) & (US$ Million) Table 120. Mexico Bendamustine Revenue (2021-2032) & (US$ Million) Table 121. Europe Bendamustine Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Bendamustine Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Bendamustine Sales by Type (2021-2026) & (K Units) Table 124. Europe Bendamustine Sales by Type (2027-2032) & (K Units) Table 125. Europe Bendamustine Sales Price by Type (2021-2026) & (USD/Unit) Table 126. Europe Bendamustine Sales Price by Type (2027-2032) & (USD/Unit) Table 127. Europe Bendamustine Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Bendamustine Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Bendamustine Sales by Application (2021-2026) & (K Units) Table 130. Europe Bendamustine Sales by Application (2027-2032) & (K Units) Table 131. Europe Bendamustine Sales Price by Application (2021-2026) & (USD/Unit) Table 132. Europe Bendamustine Sales Price by Application (2027-2032) & (USD/Unit) Table 133. Europe Bendamustine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Bendamustine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Bendamustine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Bendamustine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. Europe Bendamustine Sales by Country (2021-2026) & (K Units) Table 138. Europe Bendamustine Sales by Country (2027-2032) & (K Units) Table 139. Europe Bendamustine Sales Price by Country (2021-2026) & (USD/Unit) Table 140. Europe Bendamustine Sales Price by Country (2027-2032) & (USD/Unit) Table 141. Germany Bendamustine Revenue (2021-2032) & (US$ Million) Table 142. France Bendamustine Revenue (2021-2032) & (US$ Million) Table 143. U.K. Bendamustine Revenue (2021-2032) & (US$ Million) Table 144. Italy Bendamustine Revenue (2021-2032) & (US$ Million) Table 145. Russia Bendamustine Revenue (2021-2032) & (US$ Million) Table 146. Spain Bendamustine Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Bendamustine Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Bendamustine Revenue (2021-2032) & (US$ Million) Table 149. Sweden Bendamustine Revenue (2021-2032) & (US$ Million) Table 150. Poland Bendamustine Revenue (2021-2032) & (US$ Million) Table 151. China Bendamustine Revenue by Type (2021-2026) & (US$ Million) Table 152. China Bendamustine Revenue by Type (2027-2032) & (US$ Million) Table 153. China Bendamustine Sales by Type (2021-2026) & (K Units) Table 154. China Bendamustine Sales by Type (2027-2032) & (K Units) Table 155. China Bendamustine Sales Price by Type (2021-2026) & (USD/Unit) Table 156. China Bendamustine Sales Price by Type (2027-2032) & (USD/Unit) Table 157. China Bendamustine Revenue by Application (2021-2026) & (US$ Million) Table 158. China Bendamustine Revenue by Application (2027-2032) & (US$ Million) Table 159. China Bendamustine Sales by Application (2021-2026) & (K Units) Table 160. China Bendamustine Sales by Application (2027-2032) & (K Units) Table 161. China Bendamustine Sales Price by Application (2021-2026) & (USD/Unit) Table 162. China Bendamustine Sales Price by Application (2027-2032) & (USD/Unit) Table 163. Asia Bendamustine Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Bendamustine Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Bendamustine Sales by Type (2021-2026) & (K Units) Table 166. Asia Bendamustine Sales by Type (2027-2032) & (K Units) Table 167. Asia Bendamustine Sales Price by Type (2021-2026) & (USD/Unit) Table 168. Asia Bendamustine Sales Price by Type (2027-2032) & (USD/Unit) Table 169. Asia Bendamustine Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Bendamustine Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Bendamustine Sales by Application (2021-2026) & (K Units) Table 172. Asia Bendamustine Sales by Application (2027-2032) & (K Units) Table 173. Asia Bendamustine Sales Price by Application (2021-2026) & (USD/Unit) Table 174. Asia Bendamustine Sales Price by Application (2027-2032) & (USD/Unit) Table 175. Asia Bendamustine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Bendamustine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Bendamustine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Bendamustine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. Asia Bendamustine Sales by Country (2021-2026) & (K Units) Table 180. Asia Bendamustine Sales by Country (2027-2032) & (K Units) Table 181. Asia Bendamustine Sales Price by Country (2021-2026) & (USD/Unit) Table 182. Asia Bendamustine Sales Price by Country (2027-2032) & (USD/Unit) Table 183. Japan Bendamustine Revenue (2021-2032) & (US$ Million) Table 184. South Korea Bendamustine Revenue (2021-2032) & (US$ Million) Table 185. India Bendamustine Revenue (2021-2032) & (US$ Million) Table 186. Australia Bendamustine Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Bendamustine Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Bendamustine Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Bendamustine Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Bendamustine Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Bendamustine Sales by Type (2021-2026) & (K Units) Table 192. SAMEA Bendamustine Sales by Type (2027-2032) & (K Units) Table 193. SAMEA Bendamustine Sales Price by Type (2021-2026) & (USD/Unit) Table 194. SAMEA Bendamustine Sales Price by Type (2027-2032) & (USD/Unit) Table 195. SAMEA Bendamustine Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Bendamustine Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Bendamustine Sales by Application (2021-2026) & (K Units) Table 198. SAMEA Bendamustine Sales by Application (2027-2032) & (K Units) Table 199. SAMEA Bendamustine Sales Price by Application (2021-2026) & (USD/Unit) Table 200. SAMEA Bendamustine Sales Price by Application (2027-2032) & (USD/Unit) Table 201. SAMEA Bendamustine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Bendamustine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Bendamustine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Bendamustine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 205. SAMEA Bendamustine Sales by Country (2021-2026) & (K Units) Table 206. SAMEA Bendamustine Sales by Country (2027-2032) & (K Units) Table 207. SAMEA Bendamustine Sales Price by Country (2021-2026) & (USD/Unit) Table 208. SAMEA Bendamustine Sales Price by Country (2027-2032) & (USD/Unit) Table 209. Brazil Bendamustine Revenue (2021-2032) & (US$ Million) Table 210. Argentina Bendamustine Revenue (2021-2032) & (US$ Million) Table 211. Chile Bendamustine Revenue (2021-2032) & (US$ Million) Table 212. Colombia Bendamustine Revenue (2021-2032) & (US$ Million) Table 213. Peru Bendamustine Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Bendamustine Revenue (2021-2032) & (US$ Million) Table 215. Israel Bendamustine Revenue (2021-2032) & (US$ Million) Table 216. UAE Bendamustine Revenue (2021-2032) & (US$ Million) Table 217. Turkey Bendamustine Revenue (2021-2032) & (US$ Million) Table 218. Iran Bendamustine Revenue (2021-2032) & (US$ Million) Table 219. Egypt Bendamustine Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Bendamustine Distributors List Table 223. Bendamustine Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Bendamustine Image Figure 2. Global Bendamustine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bendamustine Market Size Share 2021 VS 2025 VS 2032 Figure 4. 25mg Injection Image Figure 5. 100mg Injection Image Figure 6. Others Image Figure 7. Global Bendamustine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Bendamustine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Chronic Lymphocytic Leukemia Image Figure 10. Multiple Myeloma Image Figure 11. Non-Hodgkin's Lymphoma Image Figure 12. Global Bendamustine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Bendamustine Revenue (2021-2032) & (US$ Million) Figure 14. Global Bendamustine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Bendamustine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Bendamustine Revenue Market Share by Region (2021-2032) Figure 17. Global Bendamustine Sales (2021-2032) & (K Units) Figure 18. Global Bendamustine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Bendamustine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Bendamustine Sales YoY (2021-2032) & (K Units) Figure 21. Europe Bendamustine Sales YoY (2021-2032) & (K Units) Figure 22. China Bendamustine Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Bendamustine Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Bendamustine Sales YoY (2021-2032) & (K Units) Figure 25. Global Bendamustine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Bendamustine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Bendamustine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Bendamustine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Bendamustine Revenue Market Share by Type (2021-2032) Figure 31. Global Bendamustine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Bendamustine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Bendamustine Sales Market Share by Type (2021-2032) Figure 34. Global Bendamustine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Bendamustine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Bendamustine Revenue Market Share by Application (2021-2032) Figure 37. Global Bendamustine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Bendamustine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Bendamustine Sales Market Share by Application (2021-2032) Figure 40. North America Bendamustine Revenue Share by Type (2021-2032) Figure 41. North America Bendamustine Sales Share by Type (2021-2032) Figure 42. North America Bendamustine Revenue Share by Application (2021-2032) Figure 43. North America Bendamustine Sales Share by Application (2021-2032) Figure 44. North America Bendamustine Revenue Share by Country (2021-2032) Figure 45. North America Bendamustine Sales Share by Country (2021-2032) Figure 46. Europe Bendamustine Revenue Share by Type (2021-2032) Figure 47. Europe Bendamustine Sales Share by Type (2021-2032) Figure 48. Europe Bendamustine Revenue Share by Application (2021-2032) Figure 49. Europe Bendamustine Sales Share by Application (2021-2032) Figure 50. Europe Bendamustine Revenue Share by Country (2021-2032) Figure 51. Europe Bendamustine Sales Share by Country (2021-2032) Figure 52. China Bendamustine Revenue Share by Type (2021-2032) Figure 53. China Bendamustine Sales Share by Type (2021-2032) Figure 54. China Bendamustine Revenue Share by Application (2021-2032) Figure 55. China Bendamustine Sales Share by Application (2021-2032) Figure 56. Asia Bendamustine Revenue Share by Type (2021-2032) Figure 57. Asia Bendamustine Sales Share by Type (2021-2032) Figure 58. Asia Bendamustine Revenue Share by Application (2021-2032) Figure 59. Asia Bendamustine Sales Share by Application (2021-2032) Figure 60. Asia Bendamustine Revenue Share by Country (2021-2032) Figure 61. Asia Bendamustine Sales Share by Country (2021-2032) Figure 62. SAMEA Bendamustine Revenue Share by Type (2021-2032) Figure 63. SAMEA Bendamustine Sales Share by Type (2021-2032) Figure 64. SAMEA Bendamustine Revenue Share by Application (2021-2032) Figure 65. SAMEA Bendamustine Sales Share by Application (2021-2032) Figure 66. SAMEA Bendamustine Revenue Share by Country (2021-2032) Figure 67. SAMEA Bendamustine Sales Share by Country (2021-2032) Figure 68. Bendamustine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Bendamustine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg Injection
  • 100mg Injection
  • Others
Applications
  • Chronic Lymphocytic Leukemia
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
Companies covered
  • Teva
  • Eisai
  • Eagle Pharmaceuticals
  • MundiPharma
  • Mylan
  • Natco Pharma
  • Emcure
  • Miracalus Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bendamustine Market by Type
  3. 1.2.1 Global Bendamustine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 25mg Injection
  5. 1.2.3 100mg Injection
  6. 1.2.4 Others
  7. 1.3 Bendamustine Market by Application
  8. 1.3.1 Global Bendamustine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Chronic Lymphocytic Leukemia
  10. 1.3.3 Multiple Myeloma
  11. 1.3.4 Non-Hodgkin's Lymphoma
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Bendamustine Market Dynamics
  1. 2.1 Bendamustine Industry Trends
  2. 2.2 Bendamustine Industry Drivers
  3. 2.3 Bendamustine Industry Opportunities and Challenges
  4. 2.4 Bendamustine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Bendamustine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Bendamustine Revenue by Region
  3. 3.2.1 Global Bendamustine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bendamustine Revenue by Region (2021-2026)
  5. 3.2.3 Global Bendamustine Revenue by Region (2027-2032)
  6. 3.2.4 Global Bendamustine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Bendamustine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Bendamustine Sales by Region
  9. 3.4.1 Global Bendamustine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Bendamustine Sales by Region (2021-2026)
  11. 3.4.3 Global Bendamustine Sales by Region (2027-2032)
  12. 3.4.4 Global Bendamustine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Bendamustine Revenue by Manufacturers
  2. 4.1.1 Global Bendamustine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Bendamustine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Bendamustine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bendamustine Sales by Manufacturers
  6. 4.2.1 Global Bendamustine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Bendamustine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Bendamustine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Bendamustine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Bendamustine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Bendamustine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Bendamustine Manufacturers, Product Type & Application
  13. 4.7 Global Bendamustine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Bendamustine Market CR5 and HHI
  16. 4.8.2 2025 Bendamustine Tier 1, Tier 2, and Tier 3
5 Bendamustine Market by Type
  1. 5.1 Global Bendamustine Revenue by Type
  2. 5.1.1 Global Bendamustine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Bendamustine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Bendamustine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Bendamustine Sales by Type
  6. 5.2.1 Global Bendamustine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bendamustine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Bendamustine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Bendamustine Price by Type
6 Bendamustine Market by Application
  1. 6.1 Global Bendamustine Revenue by Application
  2. 6.1.1 Global Bendamustine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Bendamustine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Bendamustine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Bendamustine Sales by Application
  6. 6.2.1 Global Bendamustine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Bendamustine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Bendamustine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Bendamustine Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Bendamustine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Bendamustine Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Eisai
  8. 7.2.1 Eisai Company Information
  9. 7.2.2 Eisai Business Overview
  10. 7.2.3 Eisai Bendamustine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eisai Bendamustine Product Portfolio
  12. 7.2.5 Eisai Recent Developments
  13. 7.3 Eagle Pharmaceuticals
  14. 7.3.1 Eagle Pharmaceuticals Company Information
  15. 7.3.2 Eagle Pharmaceuticals Business Overview
  16. 7.3.3 Eagle Pharmaceuticals Bendamustine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eagle Pharmaceuticals Bendamustine Product Portfolio
  18. 7.3.5 Eagle Pharmaceuticals Recent Developments
  19. 7.4 MundiPharma
  20. 7.4.1 MundiPharma Company Information
  21. 7.4.2 MundiPharma Business Overview
  22. 7.4.3 MundiPharma Bendamustine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 MundiPharma Bendamustine Product Portfolio
  24. 7.4.5 MundiPharma Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Bendamustine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Bendamustine Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 Natco Pharma
  32. 7.6.1 Natco Pharma Company Information
  33. 7.6.2 Natco Pharma Business Overview
  34. 7.6.3 Natco Pharma Bendamustine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Natco Pharma Bendamustine Product Portfolio
  36. 7.6.5 Natco Pharma Recent Developments
  37. 7.7 Emcure
  38. 7.7.1 Emcure Company Information
  39. 7.7.2 Emcure Business Overview
  40. 7.7.3 Emcure Bendamustine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Emcure Bendamustine Product Portfolio
  42. 7.7.5 Emcure Recent Developments
  43. 7.8 Miracalus Pharma
  44. 7.8.1 Miracalus Pharma Company Information
  45. 7.8.2 Miracalus Pharma Business Overview
  46. 7.8.3 Miracalus Pharma Bendamustine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Miracalus Pharma Bendamustine Product Portfolio
  48. 7.8.5 Miracalus Pharma Recent Developments
8 North America
  1. 8.1 North America Bendamustine Market Size by Type
  2. 8.1.1 North America Bendamustine Revenue by Type (2021-2032)
  3. 8.1.2 North America Bendamustine Sales by Type (2021-2032)
  4. 8.1.3 North America Bendamustine Price by Type (2021-2032)
  5. 8.2 North America Bendamustine Market Size by Application
  6. 8.2.1 North America Bendamustine Revenue by Application (2021-2032)
  7. 8.2.2 North America Bendamustine Sales by Application (2021-2032)
  8. 8.2.3 North America Bendamustine Price by Application (2021-2032)
  9. 8.3 North America Bendamustine Market Size by Country
  10. 8.3.1 North America Bendamustine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Bendamustine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Bendamustine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Bendamustine Market Size by Type
  2. 9.1.1 Europe Bendamustine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Bendamustine Sales by Type (2021-2032)
  4. 9.1.3 Europe Bendamustine Price by Type (2021-2032)
  5. 9.2 Europe Bendamustine Market Size by Application
  6. 9.2.1 Europe Bendamustine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Bendamustine Sales by Application (2021-2032)
  8. 9.2.3 Europe Bendamustine Price by Application (2021-2032)
  9. 9.3 Europe Bendamustine Market Size by Country
  10. 9.3.1 Europe Bendamustine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Bendamustine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Bendamustine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Bendamustine Market Size by Type
  2. 10.1.1 China Bendamustine Revenue by Type (2021-2032)
  3. 10.1.2 China Bendamustine Sales by Type (2021-2032)
  4. 10.1.3 China Bendamustine Price by Type (2021-2032)
  5. 10.2 China Bendamustine Market Size by Application
  6. 10.2.1 China Bendamustine Revenue by Application (2021-2032)
  7. 10.2.2 China Bendamustine Sales by Application (2021-2032)
  8. 10.2.3 China Bendamustine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bendamustine Market Size by Type
  2. 11.1.1 Asia Bendamustine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Bendamustine Sales by Type (2021-2032)
  4. 11.1.3 Asia Bendamustine Price by Type (2021-2032)
  5. 11.2 Asia Bendamustine Market Size by Application
  6. 11.2.1 Asia Bendamustine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Bendamustine Sales by Application (2021-2032)
  8. 11.2.3 Asia Bendamustine Price by Application (2021-2032)
  9. 11.3 Asia Bendamustine Market Size by Country
  10. 11.3.1 Asia Bendamustine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Bendamustine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Bendamustine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bendamustine Market Size by Type
  2. 12.1.1 SAMEA Bendamustine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Bendamustine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Bendamustine Price by Type (2021-2032)
  5. 12.2 SAMEA Bendamustine Market Size by Application
  6. 12.2.1 SAMEA Bendamustine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Bendamustine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Bendamustine Price by Application (2021-2032)
  9. 12.3 SAMEA Bendamustine Market Size by Country
  10. 12.3.1 SAMEA Bendamustine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Bendamustine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Bendamustine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Bendamustine Value Chain Analysis
  2. 13.1.1 Bendamustine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Bendamustine Production Mode & Process
  6. 13.2 Bendamustine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Bendamustine Distributors
  9. 13.2.3 Bendamustine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst